Immunomedics' Data Is Good News for Seattle Genetics, Too
Seattle Genetics could do handsomely following positive midstage study results for Immunomedics' lead drug.
Friday, December 8, 2017
Immunomedics' Data Is Good News for Seattle Genetics, Too
Immunomedics' Data Is Good News for Seattle Genetics, Too
Seattle Genetics could do handsomely following positive midstage study results for Immunomedics' lead drug.
0 comments:
Post a Comment